SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001485003-18-000049
Filing Date
2018-04-30
Accepted
2018-04-30 16:07:21
Documents
4
Period of Report
2018-06-12
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A ebio2018proxystatement.htm DEF 14A 564605
2 ebiologoa38.jpg GRAPHIC 89522
3 hurleysignaturea04.jpg GRAPHIC 48456
4 hurleysignaturea05.jpg GRAPHIC 48456
  Complete submission text file 0001485003-18-000049.txt   822458
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 18789715
SIC: 2834 Pharmaceutical Preparations